Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women

Iron deficiency (ID) and iron deficiency anemia (IDA) are the most common iron disorders throughout the world. ID and IDA, particularly caused by increased iron requirements during pregnancy, represent a high risk for preterm delivery, fetal growth retardation, low birth weight, and inferior neonata...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biometals 2010-06, Vol.23 (3), p.411-417
Hauptverfasser: Paesano, Rosalba, Berlutti, Francesca, Pietropaoli, Miriam, Pantanella, Fabrizio, Pacifici, Enrica, Goolsbee, William, Valenti, Piera
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 417
container_issue 3
container_start_page 411
container_title Biometals
container_volume 23
creator Paesano, Rosalba
Berlutti, Francesca
Pietropaoli, Miriam
Pantanella, Fabrizio
Pacifici, Enrica
Goolsbee, William
Valenti, Piera
description Iron deficiency (ID) and iron deficiency anemia (IDA) are the most common iron disorders throughout the world. ID and IDA, particularly caused by increased iron requirements during pregnancy, represent a high risk for preterm delivery, fetal growth retardation, low birth weight, and inferior neonatal health. Oral administration of ferrous sulfate to cure ID and IDA in pregnancy often fails to increase hematological parameters, causes adverse effects and increases inflammation. Recently, we have demonstrated safety and efficacy of oral administration of 30% iron saturated bovine lactoferrin (bLf) in pregnant women suffering from ID and IDA. Oral administration of bLf significantly increases the number of red blood cells, hemoglobin, total serum iron and serum ferritin already after 30 days of the treatment. The increasing of hematological values by bLf is related to the decrease of serum IL-6 and the increase of serum hepcidin, detected as prohepcidin, whereas ferrous sulfate increases IL-6 and fails to increase hematological parameters and prohepcidin. bLf is a more effective and safer alternative than ferrous sulfate for treating ID and IDA in pregnant women.
doi_str_mv 10.1007/s10534-010-9335-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_753732383</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>753732383</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-547b0e7977ba3070de60d36c17027d8c0217374f86d78f9e7dcf0447b6d71f063</originalsourceid><addsrcrecordid>eNqFkU1LxDAQhoMo7rr6A7xI8eKpOmnaTnuUxS9Y8KLnkE0nS5d-rEmruL_elK4KongaMjzvOzN5GTvlcMkB8MpxSEQcAocwFyIJt3tsyhOMwgxR7LMp5GkaQhbHE3bk3BoAcoT0kE0iiAEzSKbMLpTuWkPWlk1AxpRa6ffglazrXTC0W19dXxnVUeAR3XtwFZS2bYKCPF5S4wWqKX7pUV2qQbSxtGpU0wVvbU3NMTswqnJ0sqsz9nx78zS_DxePdw_z60Wo4zTrwiTGJRDmiEslAKGgFAqRao4QYZFpiDgKjE2WFpiZnLDQBmIv8m9uIBUzdjH6bmz70pPrZF06TVXlF_NXSUwEikhk4n_Sfy7HBAfy_Ae5bnvb-DNkFIkEPTYM5iOkbeucJSM3tqyVfZcc5BCcHIOTPjg5BCe3XnO2M-6XNRVfis-kPBCNgNsMCZD9nvy36weaoaQb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223575176</pqid></control><display><type>article</type><title>Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women</title><source>MEDLINE</source><source>SpringerLink (Online service)</source><creator>Paesano, Rosalba ; Berlutti, Francesca ; Pietropaoli, Miriam ; Pantanella, Fabrizio ; Pacifici, Enrica ; Goolsbee, William ; Valenti, Piera</creator><creatorcontrib>Paesano, Rosalba ; Berlutti, Francesca ; Pietropaoli, Miriam ; Pantanella, Fabrizio ; Pacifici, Enrica ; Goolsbee, William ; Valenti, Piera</creatorcontrib><description>Iron deficiency (ID) and iron deficiency anemia (IDA) are the most common iron disorders throughout the world. ID and IDA, particularly caused by increased iron requirements during pregnancy, represent a high risk for preterm delivery, fetal growth retardation, low birth weight, and inferior neonatal health. Oral administration of ferrous sulfate to cure ID and IDA in pregnancy often fails to increase hematological parameters, causes adverse effects and increases inflammation. Recently, we have demonstrated safety and efficacy of oral administration of 30% iron saturated bovine lactoferrin (bLf) in pregnant women suffering from ID and IDA. Oral administration of bLf significantly increases the number of red blood cells, hemoglobin, total serum iron and serum ferritin already after 30 days of the treatment. The increasing of hematological values by bLf is related to the decrease of serum IL-6 and the increase of serum hepcidin, detected as prohepcidin, whereas ferrous sulfate increases IL-6 and fails to increase hematological parameters and prohepcidin. bLf is a more effective and safer alternative than ferrous sulfate for treating ID and IDA in pregnant women.</description><identifier>ISSN: 0966-0844</identifier><identifier>EISSN: 1572-8773</identifier><identifier>DOI: 10.1007/s10534-010-9335-z</identifier><identifier>PMID: 20407805</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Anemia ; Anemia, Iron-Deficiency - drug therapy ; Anemias ; Animals ; Biochemistry ; Biomedical and Life Sciences ; Cell Biology ; Cures ; Female ; Ferritin ; Ferrous Compounds - administration &amp; dosage ; Ferrous Compounds - adverse effects ; Ferrous Compounds - therapeutic use ; Hematology ; Hemoglobin ; Humans ; Iron ; Iron - deficiency ; Lactoferrin - administration &amp; dosage ; Lactoferrin - immunology ; Lactoferrin - therapeutic use ; Life Sciences ; Medicine/Public Health ; Microbiology ; Nutrient deficiency ; Peptides ; Pharmacology/Toxicology ; Plant Physiology ; Pregnancy ; Pregnancy Complications, Hematologic - drug therapy ; Prenatal care ; Serums ; Sulfates</subject><ispartof>Biometals, 2010-06, Vol.23 (3), p.411-417</ispartof><rights>Springer Science+Business Media, LLC. 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-547b0e7977ba3070de60d36c17027d8c0217374f86d78f9e7dcf0447b6d71f063</citedby><cites>FETCH-LOGICAL-c468t-547b0e7977ba3070de60d36c17027d8c0217374f86d78f9e7dcf0447b6d71f063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10534-010-9335-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10534-010-9335-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20407805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paesano, Rosalba</creatorcontrib><creatorcontrib>Berlutti, Francesca</creatorcontrib><creatorcontrib>Pietropaoli, Miriam</creatorcontrib><creatorcontrib>Pantanella, Fabrizio</creatorcontrib><creatorcontrib>Pacifici, Enrica</creatorcontrib><creatorcontrib>Goolsbee, William</creatorcontrib><creatorcontrib>Valenti, Piera</creatorcontrib><title>Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women</title><title>Biometals</title><addtitle>Biometals</addtitle><addtitle>Biometals</addtitle><description>Iron deficiency (ID) and iron deficiency anemia (IDA) are the most common iron disorders throughout the world. ID and IDA, particularly caused by increased iron requirements during pregnancy, represent a high risk for preterm delivery, fetal growth retardation, low birth weight, and inferior neonatal health. Oral administration of ferrous sulfate to cure ID and IDA in pregnancy often fails to increase hematological parameters, causes adverse effects and increases inflammation. Recently, we have demonstrated safety and efficacy of oral administration of 30% iron saturated bovine lactoferrin (bLf) in pregnant women suffering from ID and IDA. Oral administration of bLf significantly increases the number of red blood cells, hemoglobin, total serum iron and serum ferritin already after 30 days of the treatment. The increasing of hematological values by bLf is related to the decrease of serum IL-6 and the increase of serum hepcidin, detected as prohepcidin, whereas ferrous sulfate increases IL-6 and fails to increase hematological parameters and prohepcidin. bLf is a more effective and safer alternative than ferrous sulfate for treating ID and IDA in pregnant women.</description><subject>Anemia</subject><subject>Anemia, Iron-Deficiency - drug therapy</subject><subject>Anemias</subject><subject>Animals</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Cell Biology</subject><subject>Cures</subject><subject>Female</subject><subject>Ferritin</subject><subject>Ferrous Compounds - administration &amp; dosage</subject><subject>Ferrous Compounds - adverse effects</subject><subject>Ferrous Compounds - therapeutic use</subject><subject>Hematology</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Iron</subject><subject>Iron - deficiency</subject><subject>Lactoferrin - administration &amp; dosage</subject><subject>Lactoferrin - immunology</subject><subject>Lactoferrin - therapeutic use</subject><subject>Life Sciences</subject><subject>Medicine/Public Health</subject><subject>Microbiology</subject><subject>Nutrient deficiency</subject><subject>Peptides</subject><subject>Pharmacology/Toxicology</subject><subject>Plant Physiology</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Hematologic - drug therapy</subject><subject>Prenatal care</subject><subject>Serums</subject><subject>Sulfates</subject><issn>0966-0844</issn><issn>1572-8773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkU1LxDAQhoMo7rr6A7xI8eKpOmnaTnuUxS9Y8KLnkE0nS5d-rEmruL_elK4KongaMjzvOzN5GTvlcMkB8MpxSEQcAocwFyIJt3tsyhOMwgxR7LMp5GkaQhbHE3bk3BoAcoT0kE0iiAEzSKbMLpTuWkPWlk1AxpRa6ffglazrXTC0W19dXxnVUeAR3XtwFZS2bYKCPF5S4wWqKX7pUV2qQbSxtGpU0wVvbU3NMTswqnJ0sqsz9nx78zS_DxePdw_z60Wo4zTrwiTGJRDmiEslAKGgFAqRao4QYZFpiDgKjE2WFpiZnLDQBmIv8m9uIBUzdjH6bmz70pPrZF06TVXlF_NXSUwEikhk4n_Sfy7HBAfy_Ae5bnvb-DNkFIkEPTYM5iOkbeucJSM3tqyVfZcc5BCcHIOTPjg5BCe3XnO2M-6XNRVfis-kPBCNgNsMCZD9nvy36weaoaQb</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Paesano, Rosalba</creator><creator>Berlutti, Francesca</creator><creator>Pietropaoli, Miriam</creator><creator>Pantanella, Fabrizio</creator><creator>Pacifici, Enrica</creator><creator>Goolsbee, William</creator><creator>Valenti, Piera</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U5</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8BQ</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JG9</scope><scope>K9.</scope><scope>L6V</scope><scope>L7M</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>P64</scope><scope>PATMY</scope><scope>PCBAR</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20100601</creationdate><title>Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women</title><author>Paesano, Rosalba ; Berlutti, Francesca ; Pietropaoli, Miriam ; Pantanella, Fabrizio ; Pacifici, Enrica ; Goolsbee, William ; Valenti, Piera</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-547b0e7977ba3070de60d36c17027d8c0217374f86d78f9e7dcf0447b6d71f063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anemia</topic><topic>Anemia, Iron-Deficiency - drug therapy</topic><topic>Anemias</topic><topic>Animals</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Cell Biology</topic><topic>Cures</topic><topic>Female</topic><topic>Ferritin</topic><topic>Ferrous Compounds - administration &amp; dosage</topic><topic>Ferrous Compounds - adverse effects</topic><topic>Ferrous Compounds - therapeutic use</topic><topic>Hematology</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Iron</topic><topic>Iron - deficiency</topic><topic>Lactoferrin - administration &amp; dosage</topic><topic>Lactoferrin - immunology</topic><topic>Lactoferrin - therapeutic use</topic><topic>Life Sciences</topic><topic>Medicine/Public Health</topic><topic>Microbiology</topic><topic>Nutrient deficiency</topic><topic>Peptides</topic><topic>Pharmacology/Toxicology</topic><topic>Plant Physiology</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Hematologic - drug therapy</topic><topic>Prenatal care</topic><topic>Serums</topic><topic>Sulfates</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paesano, Rosalba</creatorcontrib><creatorcontrib>Berlutti, Francesca</creatorcontrib><creatorcontrib>Pietropaoli, Miriam</creatorcontrib><creatorcontrib>Pantanella, Fabrizio</creatorcontrib><creatorcontrib>Pacifici, Enrica</creatorcontrib><creatorcontrib>Goolsbee, William</creatorcontrib><creatorcontrib>Valenti, Piera</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Materials Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Biometals</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paesano, Rosalba</au><au>Berlutti, Francesca</au><au>Pietropaoli, Miriam</au><au>Pantanella, Fabrizio</au><au>Pacifici, Enrica</au><au>Goolsbee, William</au><au>Valenti, Piera</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women</atitle><jtitle>Biometals</jtitle><stitle>Biometals</stitle><addtitle>Biometals</addtitle><date>2010-06-01</date><risdate>2010</risdate><volume>23</volume><issue>3</issue><spage>411</spage><epage>417</epage><pages>411-417</pages><issn>0966-0844</issn><eissn>1572-8773</eissn><abstract>Iron deficiency (ID) and iron deficiency anemia (IDA) are the most common iron disorders throughout the world. ID and IDA, particularly caused by increased iron requirements during pregnancy, represent a high risk for preterm delivery, fetal growth retardation, low birth weight, and inferior neonatal health. Oral administration of ferrous sulfate to cure ID and IDA in pregnancy often fails to increase hematological parameters, causes adverse effects and increases inflammation. Recently, we have demonstrated safety and efficacy of oral administration of 30% iron saturated bovine lactoferrin (bLf) in pregnant women suffering from ID and IDA. Oral administration of bLf significantly increases the number of red blood cells, hemoglobin, total serum iron and serum ferritin already after 30 days of the treatment. The increasing of hematological values by bLf is related to the decrease of serum IL-6 and the increase of serum hepcidin, detected as prohepcidin, whereas ferrous sulfate increases IL-6 and fails to increase hematological parameters and prohepcidin. bLf is a more effective and safer alternative than ferrous sulfate for treating ID and IDA in pregnant women.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>20407805</pmid><doi>10.1007/s10534-010-9335-z</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0966-0844
ispartof Biometals, 2010-06, Vol.23 (3), p.411-417
issn 0966-0844
1572-8773
language eng
recordid cdi_proquest_miscellaneous_753732383
source MEDLINE; SpringerLink (Online service)
subjects Anemia
Anemia, Iron-Deficiency - drug therapy
Anemias
Animals
Biochemistry
Biomedical and Life Sciences
Cell Biology
Cures
Female
Ferritin
Ferrous Compounds - administration & dosage
Ferrous Compounds - adverse effects
Ferrous Compounds - therapeutic use
Hematology
Hemoglobin
Humans
Iron
Iron - deficiency
Lactoferrin - administration & dosage
Lactoferrin - immunology
Lactoferrin - therapeutic use
Life Sciences
Medicine/Public Health
Microbiology
Nutrient deficiency
Peptides
Pharmacology/Toxicology
Plant Physiology
Pregnancy
Pregnancy Complications, Hematologic - drug therapy
Prenatal care
Serums
Sulfates
title Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A33%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lactoferrin%20efficacy%20versus%20ferrous%20sulfate%20in%20curing%20iron%20deficiency%20and%20iron%20deficiency%20anemia%20in%20pregnant%20women&rft.jtitle=Biometals&rft.au=Paesano,%20Rosalba&rft.date=2010-06-01&rft.volume=23&rft.issue=3&rft.spage=411&rft.epage=417&rft.pages=411-417&rft.issn=0966-0844&rft.eissn=1572-8773&rft_id=info:doi/10.1007/s10534-010-9335-z&rft_dat=%3Cproquest_cross%3E753732383%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223575176&rft_id=info:pmid/20407805&rfr_iscdi=true